Citius Pharmaceuticals (CTXR)

Citius Pharmaceuticals (CTXR) Financial Statements


Citius Pharmaceuticals Financial Overview

Citius Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.191; its P/E ratio is -5.09; Citius Pharmaceuticals is scheduled to report earnings on May 11, 2023, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 0.00-$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT$ -7.25M-$ -8.86M$ -7.56M$ -9.23M
EBITDA$ -7.20M-$ -8.82M$ -7.52M$ -9.18M
Net Income Common Stockholders$ -3.59M-$ -8.86M$ -7.56M$ -9.23M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 36.89M-$ 48.04M$ 55.76M$ 65.42M
Total Assets$ 111.71M-$ 120.32M$ 127.79M$ 137.52M
Total Debt$ 630.75K$ 0.00$ 724.78K$ 769.22K$ 812.77K
Net Debt$ -36.26M$ 0.00$ -47.32M$ -54.99M$ -64.61M
Total Liabilities$ 10.67M-$ 9.98M$ 9.59M$ 12.96M
Stockholders Equity$ 100.43M-$ 109.74M$ 117.60M$ 123.96M
Cash Flow-
Free Cash Flow$ -4.82M-$ -7.71M$ -9.67M$ -4.65M
Operating Cash Flow$ -4.82M-$ -7.71M$ -9.67M$ -4.65M
Investing Cash Flow$ 0.00----
Financing Cash Flow$ 0.00-$ 0.00$ 0.00$ 0.00
Currency in USD

Citius Pharmaceuticals Earnings and Revenue History

Citius Pharmaceuticals Debt to Assets

Citius Pharmaceuticals Cash Flow

Citius Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis